| Donald R Carter, MD | |
|
711 Stanton L Young Blvd, Ppob619, Oklahoma City, OK 73104-5023 | |
| (405) 271-5781 | |
| Not Available |
| Full Name | Donald R Carter |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 711 Stanton L Young Blvd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063481091 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 7622 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald R Carter, MD 1122 Ne 13th St, Ori236, Oklahoma City, OK 73117-1039 Ph: (405) 271-5781 | Donald R Carter, MD 711 Stanton L Young Blvd, Ppob619, Oklahoma City, OK 73104-5023 Ph: (405) 271-5781 |
News Archive
The rate of men dying from malignant melanoma has risen in populations around the world, while in some countries the rates are steady or falling for women, according to research presented at the 2018 NCRI Cancer Conference.
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement today on a new study published in the Journal of the American Medical Association that found "implementation of Medicare Part D was followed by a significant reductions in nondrug medical spending, particularly on acute and post acute care, for elderly Medicare beneficiaries with limited prior drug coverage".
A new expert panel report on food security in Northern Canada, has found that food insecurity among northern Aboriginal peoples requires urgent attention in order to mitigate impacts on health and well-being.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
The FTO gene is obesity's main ally. Several studies are now attempting to reveal the factors that play a key role in fighting against it. A new study led by Spanish researchers shows that a physically active lifestyle during adolescence can reduce the effect of a mutation in this gene which predisposes someone to becoming overweight or obese.
› Verified 7 days ago
Dr. Beverly Jean Talbert, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 825 Ne 10th St, Oupb5350, Oklahoma City, OK 73104 Phone: 405-271-4864 Fax: 405-271-1643 | |
Michael Taylor Heath, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6308 | |
Dr. Teresa Marie Shavney, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Nw Expressway, Suite 420, Oklahoma City, OK 73112 Phone: 405-713-9935 Fax: 405-713-9936 | |
Dr. Mary Kathleen Lindemuth, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 10900 Hefner Pointe Dr, Oklahoma City, OK 73120 Phone: 405-552-0400 Fax: 405-752-4251 | |
John Stephen Chaffin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 760, Oklahoma City, OK 73112 Phone: 405-951-4345 Fax: 405-951-4392 | |
Juan Claros-sorto, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6308 | |
Ananth Srinivasan, MBBS Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Nw Expressway, Oklahoma City, OK 73112 Phone: 405-949-3349 Fax: 405-945-5467 |